Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 7, 2025 • 8:31 PM ET

Date/Time Source News Release
07/16/2025 08:00 AM EDT GlobeNewswire Cue Biopharma Reports New Complete Response and Confirmed 50% Overall Response Rate in Ongoing Phase 1 Trial of CUE-101 and Pembrolizumab in Recurrent/Metastatic HPV+ Head and Neck Cancer
07/01/2025 04:05 PM EDT GlobeNewswire Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies
06/24/2025 04:48 PM EDT GlobeNewswire Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company's Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease
05/12/2025 04:05 PM EDT GlobeNewswire Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights
05/08/2025 08:00 AM EDT GlobeNewswire Cue Biopharma to Host Virtual Investor Event on May 15, 2025
05/05/2025 10:00 AM EDT GlobeNewswire Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference
04/14/2025 10:23 PM EDT GlobeNewswire Cue Biopharma Announces Pricing of Approximately $20 Million Public Offering
04/14/2025 05:05 PM EDT GlobeNewswire Cue Biopharma Announces Proposed Public Offering
04/14/2025 05:02 PM EDT GlobeNewswire Cue Biopharma to Host Business Update Call and Webcast
04/14/2025 05:00 PM EDT GlobeNewswire Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
Page

Additional News

As of August 7, 2025 • 8:31 PM ET

Date/Time Source News Release
08/07/2025 06:00 PM EDT Zacks scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates
07/23/2025 09:28 AM EDT USA News Group High?Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds
05/12/2025 05:27 PM EDT SeekingAlpha Cue Biopharma GAAP EPS of -$0.17 misses by $0.02, revenue of $0.42M misses by $0.85M
05/12/2025 05:10 PM EDT Zacks Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 05:31 AM EDT US Earnings Reports Expected earnings - Cue Biopharma Inc.
05/07/2025 06:30 PM EDT Zacks MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates
05/02/2025 10:00 AM EDT Zacks Earnings Preview: Opus Genetics, Inc. (IRD) Q1 Earnings Expected to Decline
05/01/2025 10:01 AM EDT Zacks Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know
04/15/2025 06:12 PM EDT SeekingAlpha Cue Biopharma, Inc. (CUE) Business Update Call (Transcript)
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.